Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 324-328

  Bauer, Claudia C ^a   Jaksch, Peter ^b   Aberle, Stephan W ^a   Haber, Heinrich ^c   Lang, Gyoergy ^b   Klepetko, Walter ^b   Hofmann, Hanns ^a   Puchhammer Stöckl, Elisabeth ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c OTTO WAGNER HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

UREA; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DILUTION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN HERPESVIRUS 6; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL ANALYSIS; VIREMIA; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; ROSEOLOVIRUS INFECTIONS; VIRAL LOAD;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6;

EID: 33847023002     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01173-06     Document Type: Article

References (27)

1. Aberle, S. W., and E. Puchhammer-Stockl. 2002. Diagnosis of herpesvirus infections of the central nervous system. J. Clin. Virol. 25(Suppl. 1):S79-S85.
2. Arcenas, R., and R. H. Widen. 2002. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol: 2:20.
3. Balthesen, M., M. Messerle, and M. J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366.
4. Buffone, G. J., A. Frost, T. Samo, G. J. Demmler, P. T. Cagle, and E. C. Lawrence. 1993. The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation 56:342-347.
5. Cainelli, F., and S. Vento. 2002. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect. Dis. 2:539-549.
6. Campadelli-Fiume, G., P. Mirandola, and L. Menotti. 1999. Human herpesvirus 6: an emerging pathogen. Emerg. Infect. Dis. 5:353-366.
7. Chemaly, R. F., B. Yen-Lieberman, J. Chapman, A. Reilly, B. N. Bekele, S. M. Gordon, G. W. Procop, N. Shrestha, C. M. Isada, M. Decamp, and R. K. Avery. 2005. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am. J. Transplant. 5:544-548.
8. Egan, J. J., J. P. Stewart, P. S. Hasleton, J. R. Arrand, K. B. Carroll, and A. A. Woodcock. 1995. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50:1234-1239.
9. Hornef, M. W., G. Bein, L. Fricke, J. Steinhoff, H. J. Wagner, W. Hinderer, H. H. Sonneborn, and H. Kirchner. 1995. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 60:474-480.
10. Jacobs, F., C. Knoop, F. Brancart, P. Gilot, C. Melot, B. Byl, M. L. Delforge, M. Estenne, and C. Liesnard. 2003. Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study. Transplantation 75:1996-2001.
11. Khameneh, Z. R., J. Soin, M. Durlik, M. Lao, L. Paczek, and Z. Gaciong. 1999. Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation. Ann. Transplant. 4:18-22.
12. Ljungman, P., and S. A. Plotkin. 1995. Workshop on CMV disease: definitions, clinical severity scores, and new syndromes. Scand. J. Infect. Dis. Suppl. 99:87-89.
13. Lung, M. L., W. K. Lam, S. Y. So, W. P. Lam, K. H. Chan, and M. H. Ng. 1985. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet i:889-892.
14. Morbini, P., and E. Arbustini. 2001. In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung. Virchows Arch. 438:558-566.
15. Neurohr, C., P. Huppmann, H. Leuchte, M. Schwaiblmair, I. Bittmann, G. Jaeger, R. Hatz, L. Frey, P. Uberfuhr, B. Reichart, and J. Behr. 2005. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am. J. Transplant. 5:2982-2991.
16. Razonable, R. R., and C. V. Paya. 2003. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 10:60-65.
17. Razonable, R. R., R. A. Brown, A. Humar, E. Covington, E. Alecock, and C. V. Paya. 2005. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J. Infect. Dis. 192:1331-1339.
18. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
19. Riise, G. C., R. Andersson, T. Bergstrom, A. Lundmark, F. N. Nilsson, and S. Olofsson. 2000. Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients. Chest 118:1653-1660.
20. Stephan, F., J. F. Bernaudin, D. Cesari, A. Fajac, D. D. Grenet, I. Caubarrere, and M. Stern. 2001. Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation. BMC Infect. Dis. 1:15.
21. Stevens, S. J., E. A. Verschuuren, I. Pronk, W. van Der Bij, M. C. Harmsen, T. H. The, C. J. Meijer, A. J. van Den Brule, and J. M. Middeldorp. 2001. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97:1165-1171.
22. Stewart, J. P., J. J. Egan, A. J. Ross, B. G. Kelly, S. S. Lok, P. S. Hasleton, and A. A. Woodcock. 1999. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 159:1336-1341.
23. van der Bij, W., and R. Speich. 2001. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin. Infect. Dis. 33(Suppl. 1):S32-S37.
24. Wagner, H. J., L. Fischer, W. J. Jabs, M. Holbe, K. Pethig, and P. Bucsky. 2002. Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 74:656-664.
25. Westall, G. P., A. Michaelides, T. J. Williams, G. I. Snell, and T. C. Kotsimbos. 2004. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J. Infect. Dis. 190:1076-1083.
26. Winston, D. J., and R. W. Busuttil. 2003. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. Transplantation 75:229-233.
27. Zedtwitz-Liebenstein, K., P. Jaksch, C. Bauer, T. Popow, W. Klepetko, H. Hofmann, and E. Puchhammer-Stockl. 2004. Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77:1897-1899.